These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11155482)

  • 41. Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial.
    Raven SFH; Hoebe CJPA; Vossen ACTM; Visser LG; Hautvast JLA; Roukens AHE; van Steenbergen JE
    Lancet Infect Dis; 2020 Jan; 20(1):92-101. PubMed ID: 31629649
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immune response to plasma-derived hepatitis B vaccine in hospital health personnel of Parma].
    Magnani G; Bertoletti A; Calzetti C; Campari M; Pizzaferri P; Schianchi C; Vitali P
    Acta Biomed Ateneo Parmense; 1989; 60(1-2):73-9. PubMed ID: 2535096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders.
    Goldwater PN
    Vaccine; 1997 Mar; 15(4):353-6. PubMed ID: 9141204
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intradermal recombinant hepatitis B vaccination (IDRV) for non-responsive healthcare workers (HCWs).
    Ghebrehewet S; Baxter D; Falconer M; Paver K
    Hum Vaccin; 2008; 4(4):280-5. PubMed ID: 18398298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized comparative trial of interferon-alpha versus placebo in hepatitis B vaccine non-responders and hyporesponders.
    Goldwater PN
    Vaccine; 1994 Apr; 12(5):410-4. PubMed ID: 8023548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance.
    Clemens R; Sänger R; Kruppenbacher J; Höbel W; Stanbury W; Bock HL; Jilg W
    Vaccine; 1997 Mar; 15(4):349-52. PubMed ID: 9141203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster.
    Bucher B; Francioli P; Geudelin B; Fritzell B; Lavanchy D; Frei PC
    Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):212-7. PubMed ID: 8050433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Investigation on immunological factors of non- and low-responders to hepatitis B vaccine].
    Fujise K; Konuma Y; Watanabe F; Takahashi H; Aiziwa Y; Saito A; Watanabe R
    Kansenshogaku Zasshi; 1993 Mar; 67(3):190-5. PubMed ID: 8486973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of IgG subclasses after anti-hepatitis B virus immunization with a recombinant vaccine.
    Honorati MC; Borzì RM; Dolzani P; Toneguzzi S; Facchini A
    Int J Clin Lab Res; 1997; 27(3):202-6. PubMed ID: 9352385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Response to supplementary vaccination with recombinant or plasma hepatitis B vaccine in healthy non-responding children.
    Cheng KF; Chang MH; Lee CY; Huang LM; Hsu HY; Lee PI; Chen CM
    Vaccine; 1994 Aug; 12(10):899-902. PubMed ID: 7975831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Inappropriate response against Hepatitis B vaccine in health personnel of the National Hospital, Paraguay.].
    Real Delor RE; Villar, G; Rigel Espínola J
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Sep; 75(3):150-155. PubMed ID: 30296021
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody response following hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?
    Dervisoglu E; Simsek M; Yilmaz A
    Clinics (Sao Paulo); 2011; 66(9):1559-62. PubMed ID: 22179159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perspectives on hepatitis B infections and the efficacy of vaccination (hepatitis B and pneumococci) in dialysis patients.
    Almroth G; Uhlin F; Ekermo B; Isaksson B; Kaijser B; Andersson B; Hahn-Zoric M; Sällberg M
    Ups J Med Sci; 2003; 108(1):61-74. PubMed ID: 12903838
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis B vaccine responsiveness in Connecticut public safety personnel.
    Roome AJ; Walsh SJ; Cartter ML; Hadler JL
    JAMA; 1993 Dec 22-29; 270(24):2931-4. PubMed ID: 8254852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B vaccination coverage among healthcare workers at a tertiary hospital in Rwanda.
    Muvunyi CM; Harelimana JD; Sebatunzi OR; Atmaprakash AC; Seruyange E; Masaisa F; Manzi O; Nyundo M; Hategekimana T
    BMC Res Notes; 2018 Dec; 11(1):886. PubMed ID: 30545400
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-HBs levels after hepatitis B immunisation depend on test reagents: routinely determined 10 and 100 IU/l seroprotection levels unreliable.
    Heijtink RA; Schneeberger PM; Postma B; Crombach W
    Vaccine; 2002 Jul; 20(23-24):2899-905. PubMed ID: 12126900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No Improvement of Hepatitis B Vaccination Response in Patients Dialysed with a Polymethylmethacrylate Membrane Compared to High-Flux Polysulfone: Results of the HEPADIAL Study.
    de Précigout V; Germain C; Benard A; Lacraz A; Chauveau P; Deprele C; Seigneuric B; Pommereau A; Courivaud C; Douillet M; Taton B; Combe C; Contin-Bordes C
    Blood Purif; 2020; 49(3):265-271. PubMed ID: 31722332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine.
    Marseglia G; Alibrandi A; d'Annunzio G; Gulminetti R; Avanzini MA; Marconi M; Tinelli C; Lorini R
    Vaccine; 2000 Nov; 19(7-8):680-3. PubMed ID: 11115688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of the frequencies of various B cell populations in non-responder healthcare workers in comparison with responders to hepatitis B virus vaccination.
    Karimi S; Mehdipour F; Sarvari J; Ataollahi MR; Ramezani A; Meri S; Kalantar K
    Trans R Soc Trop Med Hyg; 2023 Sep; 117(9):628-636. PubMed ID: 37052149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh.
    Chowdhury F; Akter A; Rahman Bhuiyan T; Tauheed I; Ahmed T; Ahmmed F; Ahmed F; Karim M; Mainul Ahasan M; Rahman Mia M; Mohammad Ibna Masud M; Wahab Khan A; Masum Billah M; Nahar Z; Khan I; Rahad Hossain M; Ariful Islam AZM; Panday AS; Muktadir Rahman Ashik M; Qadri F
    Vaccine; 2021 Oct; 39(43):6385-6390. PubMed ID: 34561142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.